Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Must be male or non-pregnant female volunteers
Must be 18 to 65 yrs of age
Must have no significant active disease states
History or current evidence of disease (cardiovascular, respiratory, endocrine, renal, hepatic, hematological, or psychiatric)
Illicit drug users
Subjects who received an experimental new drug in the past 30 days
Subjects with any laboratory findings outside normal limits